H. pylori prevalence associated with endoscopic severity of erythematous gastritis

The association of H. pylori prevalence with endoscopic severity of erythematous gastritis in healthy adults

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

CRIS

Registry ID

KCT0005415

Enrollment

143

Registered

2020-09-23

Start date

2020-09-22

Completion date

Unknown

Last updated

2020-10-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Others(CLO test) : CLO test by biopsy during esophagogastroduodenoscopy

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 18~75 years old adult

Exclusion criteria

Exclusion criteria: Severe liver disease, severe kidney disease, decreased cardiopulmonary funtion, NSAIDs, antiplatelet agents, anticoagulants, steroids, antibiotics, PPI within 4weeks, history of gastric cancer, operation of stomach, Helicobacter pylori and eradication, gastric ulcer, duodenal ulcer, anemia, hematologic disease with bleeding diathesis

Design outcomes

Primary

Measure	Time frame
CLO test	—

Secondary

Measure	Time frame
CLO test	—

Countries

Korea, Republic of

Contacts

Public ContactKim Zoong

Hansol Hospital

Outcome results